HECTD2 was identified as a candidate driver gene in neuroblastoma [24] or as a potential target of miR-221, which promotes androgen-independent growth of prostate cancer cell lines [23], thus indicating an anti-proliferative role for HECTD2 in this cancer type. Here, HECTD2 is linked to prostate carcinoma.